Evidence map›Paper›PMID 36853428›Full record

ArticleCancer causes & control : CCC2023

Patient and provider-level drivers of healthcare utilization related to a diagnosis of a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS).

Maira A Castañeda-Avila, Kathleen M Mazor, Kate L Lapane, Mara M Epstein

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer causes & control : CCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maira A Castañeda-AvilaDepartment of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, 368 Plantation Street, A6-1065O, Worcester, MA, 01605, USA. maira.castanedaavila@umassmed.edu.ORCID http://orcid.org/0000-0002-2376-7656
Kathleen M MazorMeyers Health Care Institute, A Joint Endeavor of the University of Massachusetts Chan Medical School, Fallon Health, and Reliant Medical Group, Worcester, MA, USA.
Kate L LapaneDepartment of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, 368 Plantation Street, A6-1065O, Worcester, MA, 01605, USA.
Mara M EpsteinMeyers Health Care Institute, A Joint Endeavor of the University of Massachusetts Chan Medical School, Fallon Health, and Reliant Medical Group, Worcester, MA, USA.
University of Massachusetts Chan Medical School · US

Funding

The Role of Monoclonal Gammopathy of Undetermined Significance Diagnosis in Healthcare UtilizationF31CA247105 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CASTANEDA-AVILA, MAIRA A · 2020 to 2020
$28k
NCI NIH HHS F31 CA247105
6 · The paper itself

Abstract

purposeMonoclonal gammopathy of undetermined significance (MGUS) is the precursor of multiple myeloma. This qualitative study described patient (n = 14) experiences and healthcare providers' (n = 8) opinions and practices concerning care for patients with MGUS in the US.

methodsSemi-structured, in-depth interviews were analyzed using thematic analysis.

resultsWe identified six overarching themes related to the care pathway for patients with MGUS: (1) Process of MGUS diagnosis, (2) Providers' explanations, (3) Patients' understanding, (4) Impact of the diagnosis, (5) Follow-up/management, and (6) Factors influencing healthcare utilization. Patients demonstrated a basic understanding of MGUS. However, some patients felt anxiety around the diagnosis, which may affect other aspects of their lives. Non-hematologist providers report having less MGUS-specific knowledge. Older age, high-risk MGUS, and insurance coverage/healthcare costs influenced healthcare utilization.

conclusionPatients with MGUS may have difficulty processing this premalignant diagnosis. Non-hematologist providers may have gaps in knowledge around specific care for patients with MGUS.

Indexed as

Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaPrecancerous ConditionsDisease ProgressionHumansPatient Acceptance of Health CareAdultMonoclonal gammopathy of undetermined significanceMultiple myeloma patientsPrecancerous conditionsQualitative researchUnited States

Identifiers

PMID36853428
PMCPMC12794650
OpenAlexW4322616867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.